Rhesus cytomegalovirus is similar to human cytomegalovirus in susceptibility to benzimidazole nucleosides

Antimicrobial Agents and Chemotherapy

Volumn 48, Issue 7, 2004, Pages 2760-2765

  North, Thomas W ^a   Sequar, Getachew ^a   Townsend, Leroy B ^b   Drach, John C ^b   Barry, Peter A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,5,6 TRICHLORO (1 BETA DEXTRO RIBOFURANOSYL)BENZIMIDAZOLE; 5' DEOXY 2,5,6 TRICHLORO (1 BETA DEXTRO RIBOFURANOSYL)BENZIMIDAZOLE; ANTIVIRUS AGENT; BENZIMIDAZOLE DERIVATIVE; CIDOFOVIR; COMPLEMENTARY DNA; FOMIVIRSEN; FOSCARNET; GANCICLOVIR; NUCLEOSIDE ANALOG; PYRROLO[2,3 D]PYRIMIDINE NUCLEOSIDE; UMJD 1028; UMJD 1311; UMJD 1466; UMJD 828; UMJD 853; UNCLASSIFIED DRUG; VALGANCICLOVIR; VIRUS DNA;

AMINO ACID SEQUENCE; ANIMAL MODEL; ANTIVIRAL ACTIVITY; ARTICLE; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DRUG STRUCTURE; GENE AMPLIFICATION; HUMAN; HUMAN CYTOMEGALOVIRUS; NONHUMAN; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; PRIORITY JOURNAL; RHESUS CYTOMEGALOVIRUS; RHESUS MONKEY; VIRUS GENE; VIRUS INHIBITION; VIRUS REPLICATION;

AMINO ACID SEQUENCE; ANIMALS; ANTIVIRAL AGENTS; BENZIMIDAZOLES; CELLS, CULTURED; CONSERVED SEQUENCE; CYTOMEGALOVIRUS; FIBROBLASTS; HUMANS; MACACA MULATTA; MOLECULAR SEQUENCE DATA; NUCLEOSIDES; PLAQUE ASSAY; SEQUENCE HOMOLOGY, NUCLEIC ACID;

EID: 3042623963     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.48.7.2760-2765.2004     Document Type: Article

References (42)

1. Alford, C. A., and W. J. Britt. 1993. Cytomegalovirus, p. 227-255. In B. Roizman, R. J. Whitley, and C. Lopez (ed.), The human herpesviruses. Raven Press, Ltd., New York, N.Y.
2. Asher, D. M., J. C. J. Gibbs, D. J. Lang, D. C. Gadjusek, and R. M. Chanock. 1974. Persistent shedding of cytomegalovirus in the urine of healthy rhesus monkeys. Proc. Soc. Exp. Biol. Med. 145:794-801.
3. Barry, P. A., D. J. Alcendor, M. D. Power, H. Kerr, and P. A. Luciw. 1996. Nucleotide sequence and molecular analysis of the rhesus cytomegalovirus immediate-early gene and the UL121-117 open reading frames. Virology 215:61-72.
4. Baskin, G. B. 1987. Disseminated cytomegalovirus infection in immunodeficient rhesus macaques. Am. J. Pathol. 129:345-352.
5. Chang, W. L., V. Kirchoff, G. S. Pari, and P. A. Barry. 2002. Replication of rhesus cytomegalovirus in life-expanded rhesus fibroblasts expressing human telomerase. J. Virol. Methods 104:135-146.
6. Chang, W. L., A. F. Tarantal, S. S. Zhou, A. D. Borowsky, and P. A. Barry. 2002. A recombinant rhesus cytomegalovirus expressing enhanced green fluorescent protein retains the wild-type phenotype and pathogenicity in fetal macaques. J. Virol. 76:9493-9504.
7. Chang, Y.-N., K.-T. Jeang, T. Lietman, and G. S. Hayward. 1995. Structural organization of the spliced immediate-early gene complex that encodes the major acidic nuclear (IE1) and transactivator (IE2) proteins of African green monkey cytomegalovirus. J. Biomed. Sci. 2:105-130.
8. Chee, M. S., A. T. Bankier, S. Beck, R. Bohni, C. M. Brown, R. Cerny, T. Horsnell, C. A. Hutchison, T. Kouzarides, J. A. Martignetti, E. Preddie, S. C. Satchwell, P. Tomlinson, K. M. Weston, and B. G. Barrell. 1990. Analysis of the protein-coding content of the sequence of human cytomegalovirus strain AD169. Curr. Top. Microbiol. Immunol. 154:125-169.
9. Chou, S., A. Erice, M. C. Jordan, G. M. Vercellotti, K. R. Michels, C. L. Talarico, S. C. Stanat, and K. K. Biron. 1995. Analysis of the UL97 phosphotransferase coding sequence in clinical cytomegalovirus isolates and identification of mutations conferring ganciclovir resistance. J. Infect. Dis. 171:576-583.
10. Chou, S., G. Marousek, S. Guentzel, S. E. Follansbee, M. E. Poscher, J. P. Lalezari, R. C. Miner, and W. L. Drew. 1997. Evolution of mutations conferring multidrug resistance during prophylaxis and therapy for cytomegalovirus disease. J. Infect. Dis. 176:786-789.
11. Cihlar, T., M. D. Fuller, and J. M. Cherrington. 1998. Characterization of drug resistance-associated mutations in the human cytomegalovirus DNA polymerase gene by using recombinant mutant viruses generated from overlapping DNA fragments. J. Virol. 72:5927-5936.
12. Frohman, M. A., M. K. Dush, and G. R. Martin. 1988. Rapid production of full-length cDNAs from rare transcripts: amplification using a single gene-specific oligonucleotide primer. Proc. Natl. Acad. Sci. USA 85:8998-9002.
13. Hansen, S. G., L. I. Strelow, D. C. Franchi, D. G. Anders, and S. W. Wong. 2003. Complete sequence and genomic analysis of rhesus cytomegalovirus. J. Virol. 77:6620-6636.
14. Huff, J. E., R. Eberle, J. Capitanio, S.-S. Zhou, and P. A. Barry. 2003. Differential detection of B virus and rhesus cytomegalovirus in rhesus macaques. J. Gen. Virol. 84:83-92.
15. Jacobson, J. G., T. E. Renau, M. R. Nassiri, D. G. Sweier, J. M. Breitenbach, L. B. Townsend, and J. C. Drach. 1999. Nonnucleoside pyrrolopyrimidines with a unique mechanism of action against human cytomegalovirus. Antimicrob. Agents Chemother. 43:1888-1894.
16. Jacobson, M. A. 1994. Current management of cytomegalovirus disease in patients with AIDS. AIDS Res. Hum. Retrovir. 10:917-923.
17. Kaur, A., N. Kassis, C. L. Hale, M. Simon, M. Elliott, A. Gomez-Yafa, J. D. Lifson, R. C. Desrosiers, F. Wang, P. Barry, M. Mach, and R. P. Johnson. 2003. Direct relationship between suppression of virus-specific immunity and emergence of cytomegalovirus disease in simian AIDS. J. Virol. 77:5749-5758.
18. Kaur, A., M. D. Daniel, D. Hempel, D. Lee-Parritz, M. S. Hirsch, and R. P. Johnson. 1996. Cytotoxic T-lymphocyte responses to cytomegalovirus in normal and simian immunodeficiency virus-infected rhesus macaques. J. Virol. 70:7725-7733.
19. Kaur, A., M. Rosenzweig, and R. P. Johnson. 2000. Immunological memory and acquired immunodeficiency syndrome pathogenesis. Philos. Trans. R. Soc. Lond. B 355:381-390.
20. Kravitz, R. H., K. S. Sciabica, K. Cho, P. A. Luciw, and P. A. Barry. 1997. Cloning and characterization of the rhesus cytomegalovirus glycoprotein B. J. Gen. Virol. 78:2009-2013.
21. Krosky, P. M., K. Z. Borysko, M. R. Nassiri, R. V. Devivar, R. G. Ptak, M. G. Davis, K. K. Biron, L. B. Townsend, and J. C. Drach. 2002. Phosphorylation of β-D-ribosylbenzimidazoles is not required for activity against human cytomegalovirus. Antimicrob. Agents Chemother. 46:478-486.
22. Krosky, P. M., M. R. Underwood, S. R. Turk, K. W. Feng, R. K. Jain, R. G. Ptak, A. C. Westerman, K. K. Biron, L. B. Townsend, and J. C. Drach. 1998. Resistance of human cytomegalovirus to benzimidazole ribonucleosides maps to two open reading frames: UL89 and UL56. J. Virol. 72:4721-4728.
23. Lockridge, K. M., G. Sequar, S. S. Zhou, Y. Yue, C. M. Mandell, and P. A. Barry. 1999. Pathogenesis of experimental rhesus cytomegalovirus infection. J. Virol. 73:9576-9583.
24. Lockridge, K. M., S. S. Zhou, R. H. Kravitz, J. L. Johnson, E. T. Sawai, E. L. Blewett, and P. A. Barry. 2000. Primate cytomegaloviruses encode and express an IL-10-like protein. Virology 268:272-280.
25. London, W. T., A. J. Martinez, S. A. Houff, W. C. Wallen, B. L. Curfman, R. G. Traub, and J. L. Sever. 1986. Experimental congenital disease with simian cytomegalovirus in rhesus monkeys. Teratology 33:323-331.
26. Lurain, N. S., L. E. Spafford, and K. D. Thompson. 1994. Mutations in the UL97 open reading frame of human cytomegalovirus strains resistant to ganciclovir. J. Virol. 68:4427-4431.
27. Migawa, M. T., J. L. Girardet, J. A. Walker II, G. W. Koszalka, S. D. Chamberlain, J. C. Drach, and L. B. Townsend. 1998. Design, synthesis, and antiviral activity of alpha-nucleosides: D- and L-isomers of lyxofuranosyl- and (5-deoxylyxofuranosyl)benzimidazoles. J. Med. Chem. 41:1242-1251.
28. Mocarski, E. S., A. C. Liu, and R. R. Spaete. 1987. Structure and variability of the a sequence in the genome of human cytomegalovirus (Towne strain). J. Gen. Virol. 68:2223-2230.
29. Needleman, S. B., and C. D. Wunsch. 1970. A general method applicable to the search for similarities in the amino acid sequence of two proteins. J. Mol. Biol. 48:443-453.
30. Osborn, K. G., S. Prahalada, L. J. Lowenstine, M. B. Gardner, D. H. Maul, and R. V. Henrickson. 1984. The pathology of an epizootic of acquired immunodeficiency in rhesus macaques. Am. J. Pathol. 114:94-103.
31. Polis, M. A., K. M. Spooner, B. F. Baird, J. F. Manischewitz, H. S. Jaffe, P. E. Fisher, J. Falloon, R. T. Davey, Jr., J. A. Kovacs, R. E. Walker, S. M. Whitcup, R. B. Nussenblatt, H. C. Lane, and H. Masur. 1995. Anticytomegaloviral activity and safety of cidofovir in patients with human immunodeficiency virus infection and cytomegalovirus viruria. Antimicrob. Agents Chemother. 39:882-886.
32. Renau, T. E., C. Kennedy, R. G. Ptak, J. M. Breitenbach, J. C. Drach, and L. B. Townsend. 1996. Synthesis of non-nucleoside analogs of toyocamycin, sangivamycin, and thiosangivamycin: the effect of certain 4- and 4,6-substituents on the antiviral activity of pyrrolo[2,3-d]pyrimidines. J. Med. Chem. 39:3470-3476.
33. Renau, T. E., L. L. Wotring, J. C. Drach, and L. B. Townsend. 1996. Synthesis of non-nucleoside analogs of toyocamycin, sangivamycin, and thiosangivamycin: influence of various 7-substituents on antiviral activity. J. Med. Chem. 39:873-880.
34. Sarasini, A., F. Baldanti, M. Furione, C. Percivalle, R. Brerra, M. Barbi, and G. Gerna. 1995. Double resistance to ganciclovir and foscarnet of four human cytomegalovirus strains recovered from AIDS patients. J. Med. Virol. 47:237-244.
35. Sequar, G., W. J. Britt, F. D. Lakeman, K. M. Lockridge, R. P. Tarara, D. R. Canfield, S. S. Zhou, M. B. Gardner, and P. A. Barry. 2002. Experimental coinfection of rhesus macaques with rhesus cytomegalovirus and simian immunodeficiency virus: pathogenesis. J. Virol. 76:7661-7671.
36. Sullivan, V., K. K. Biron, C. L. Talarico, S. C. Stanat, M. Davis, L. M. Pozzi, and D. M. Coen. 1993. A point mutation in the human cytomegalovirus DNA polymerase gene confers resistance to ganciclovir and phosphonylmethoxyalkyl derivatives. Antimicrob. Agents Chemother. 37:19-25.
37. Swanson, R., E. Bergquam, and S. W. Wong. 1998. Characterization of rhesus cytomegalovirus genes associated with anti-viral susceptibility. Virology 240:338-348.
38. Tarantal, A. F., S. Salamat, W. J. Britt, P. A. Luciw, A. G. Hendrickx, and P. A. Barry. 1998. Neuropathogenesis induced by rhesus cytomegalovirus in fetal rhesus monkeys (Macaca mulatta). J. Infect. Dis. 177:446-450.
39. Townsend, L. B., R. V. Devivar, S. R. Turk, M. R. Nassiri, and J. C. Drach. 1995. Design, synthesis, and antiviral activity of certain 2,5,6-trihalo-1-(beta-D-ribofuranosyl)benzimidazoles. J. Med. Chem. 38:4098-4105.
40. Underwood, M. R., R. J. Harvey, S. C. Stanat, M. L. Hemphill, T. Miller, J. C. Drach, L. B. Townsend, and K. K. Biron. 1998. Inhibition of human cytomegalovirus DNA maturation by a benzimidazole ribonucleoside is mediated through the UL89 gene product. J. Virol. 72:717-725.
41. Vogel, P., B. J. Weigler, H. Kerr, A. Hendrickx, and P. A. Barry. 1994. Seroepidemiologic studies of cytomegalovirus infection in a breeding population of rhesus macaques. Lab. Anim. Sci. 44:25-30.
42. Williams, S. L., C. B. Hartline, N. L. Kushner, E. A. Harden, D. J. Bidanset, J. C. Drach, L. B. Townsend, M. R. Underwood, K. K. Biron, and E. R. Kern. 2003. In vitro activities of benzimidazole D- and L-ribonucleosides against herpesviruses. Antimicrob. Agents Chemother. 47:2186-2192.